Jun 22, 2026 – 4.06pmThe founder of one of Australia’s most successful technology start-ups has hit out at the self-interest of industry peers who have been lobbying the government for changes to capital gains tax rules, saying amendments announced last week gave the sector what it needs to keep growing.Tim Doyle sold his healthcare technology start-up Eucalyptus to New York-listed obesity drugs giant Hims & Hers Health for more than $1.6 billion in February, and in an article for The Australian Financial Review co-written with Eucalyptus growth manager Jae Lubberink, he accused founders in the tech sector of acting like martyrs to seek favourable treatment.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? Fetching latest articles